Use of a synthetic AAV capsid for gene therapy of muscle and central nervous system disorders - Archive ouverte HAL Accéder directement au contenu
Brevet Année : 2020

Use of a synthetic AAV capsid for gene therapy of muscle and central nervous system disorders

Fichier non déposé

Dates et versions

hal-04482827 , version 1 (28-02-2024)

Identifiants

  • HAL Id : hal-04482827 , version 1

Citer

Ana Buj-Bello, Edith Renaud-Gabardos. Use of a synthetic AAV capsid for gene therapy of muscle and central nervous system disorders. France, Patent n° : EP20305412.7. 2020. ⟨hal-04482827⟩
8 Consultations
0 Téléchargements

Partager

Gmail Facebook X LinkedIn More